DUBLIN–(BUSINESS WIRE)–The “Inhalable Drug Delivery Devices – Medical Devices Pipeline Product Landscape, 2021” report has been added to ResearchAndMarkets.com’s offering.
This report provides comprehensive information about the Inhalable Drug Delivery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Inhalable Drug Delivery device is meant to administer medications that are to be inhaled deeply into the lungs.
Scope
- Extensive coverage of the Inhalable Drug Delivery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Inhalable Drug Delivery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Inhalable Drug Delivery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
2 Introduction
3 Products under Development
3.1 Inhalable Drug Delivery Devices – Pipeline Products by Stage of Development
3.2 Inhalable Drug Delivery Devices – Pipeline Products by Segment
3.3 Inhalable Drug Delivery Devices – Pipeline Products by Territory
3.4 Inhalable Drug Delivery Devices – Pipeline Products by Regulatory Path
3.5 Inhalable Drug Delivery Devices – Pipeline Products by Estimated Approval Date
3.6 Inhalable Drug Delivery Devices – Ongoing Clinical Trials
4 Inhalable Drug Delivery Devices – Pipeline Products under Development by Companies
4.1 Inhalable Drug Delivery Companies – Pipeline Products by Stage of Development
4.2 Inhalable Drug Delivery Devices – Pipeline Products by Stage of Development
5 Inhalable Drug Delivery Companies and Product Overview
6 Inhalable Drug Delivery- Recent Developments
7 Appendix
Companies Mentioned
- Acorda Therapeutics Inc
- Actervis GmbH
- Aerami Therapeutics Inc
- Aerophase Inc
- Alexza Pharmaceuticals Inc
- Atossa Therapeutics Inc
- Baxter International Inc
- Bellerophon Therapeutics Inc
- Breath Therapeutics Holding BV
- California Northstate University College of Medicine
- Canigma A.L LTD
- Edixomed Ltd
- Engage Therapeutics Inc
- iDTx Systems, Inc.
- Impel NeuroPharma Inc
- Inhalation Sciences Sweden AB
- InhaleRx Ltd
- Invero Pharma LLC
- Jupiter Research LLC
- Kanabo Research Ltd
- Mallinckrodt Plc
- Medical Developments International Ltd
- Medspray BV
- Monash University
- Nemera La Verpilliere
- Next Safety, Inc.
- Nobilis Therapeutics Inc
- OncoSec Medical Inc
- Parnell Pharmaceuticals Inc
- Pharmosa Biopharm Inc
- Rhinomed Limited
- Rutgers Cancer Institute of New Jersey
- Sandoz International GmbH
- Seng Vital International GmbH
- Shenzhen Smoore Technology Ltd
- Technology Commercialization Partners LLC
- Tetra Bio-Pharma Inc
- Teva Pharmaceutical Industries Ltd
- Texas Tech University Health Sciences Center
- Third Pole Inc
- Tiziana Life Sciences PLC
- Torrent Pharmaceuticals Ltd
- University Hospital Southampton NHS Foundation Trust
- University of Texas Health Science Center at Houston
- Vectura Group Plc
- Veoli Ltd
- Vero Biotech LLC
- Via Therapeutics LLC
- Virpax Pharmaceuticals Inc
- VistaGen Therapeutics Inc
- VitalMIST
- Windtree Therapeutics Inc
For more information about this report visit https://www.researchandmarkets.com/r/ryyqk1
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900